Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Cuomo's cautiously upbeat report at a daily briefing came as the daily death toll across the state, the epicenter of the pandemic in the United States, dropped to 540 on April 17, down from 630 a day earlier and the lowest in more than two weeks. The governor said total hospitalizations of patients being treated for COVID-19, the respiratory illness caused by the coronavirus, came to 16,967, a drop of more than 1,300 over the past three days. Intubations and admissions to intensive care units also continued on their downward trend. "If you look at the past three days, you could argue that we are past the plateau and we're starting to descend which would be very good news," Cuomo said. He said, however, that about 2,000 infected people were newly admitted to hospitals on Friday, which he characterized as "still an overwhelming number," and reiterated that he would take a cautious approach to reopening businesses and schools. Cuomo repeated a call for the federal government to help coordinate and provide funding for the mass testing that he and other governors have said is needed to determine when it is safe for people to go back to work. Providing new details on the challenge, Cuomo said a survey of labs in his state revealed an inability to procure the chemical reagents needed to run the tests on machines supplied by private manufacturers like Roche Holding AG. "They bought the machine, they have the machine, they have the test, but they need the reagents to do a higher volume of tests," Cuomo said, adding that makers like Roche are struggling to get the reagents from China. "That's the logjam we are in." New York disclosed 7,090 new positive cases over the last 24 hours for a total of 236,732 cases, while deaths increased by 540 to 13,362, marking by far the largest number of fatalities of any state. Even with stabilizing numbers, Cuomo said the pandemic was taking a severe emotional and economic toll on people, and estimated the impact on society would prove to be the biggest challenge facing the country since World War Two. "On every level this is a terrible experience, Cuomo said. "It is as tumultuous a time as we have ever seen."
New York Governor sounds optimistic note as coronavirus numbers improve.

Scientists with the National Oceanic and Atmospheric Administration expect this year's bloom to rank among the top five since it began measuring their severity in 2002, according to their annual algae forecast for the lake. What's not known is how toxic it might be or whether it will pose a threat for cities in Ohio and Michigan that draw their drinking water from the lake. Algae blooms that produce toxins and can sicken swimmers and harm fish are becoming an increasing concern nationwide, causing water warnings this year from Vermont to the Gulf Coast. Environmental officials in New Jersey have been telling people to stay out of the state's largest lake since late June and beaches in Mississippi have been closed in recent weeks by a bloom fueled by polluted Midwest floodwaters pouring from the Mississippi River. Lake Erie, the shallowest and warmest of the Great Lakes, has been hit particularly hard over the past decade. It was five years ago when a toxic bloom caused a two-day shutdown of drinking water in Toledo. Researchers, using a scale for rating the severity of the bloom, expect it to be a 7.5 this year short of the most severe outbreaks this past decade but still a significant one. Studies have shown that much of the phosphorus that fuels the algae comes from fertilizer runoff from farm fields along with sewage treatment plants and other sources. Unusually heavy rains this spring washed large amounts of nutrients into the lake, but the rain also prevented many farmers from planting corn and applying phosphorus-rich fertilizers on their fields. That may be why the amount of phosphorus found in the lake's largest tributary, the Maumee River, was much lower than what would be expected, said Laura Johnson, director of the National Center for Water Quality Research at Heidelberg University. The forecasters say one thing they're unsure about is how the record-setting water levels on the lake this year will impact the algae. "Each bloom is different in how they behave," said Rick Stumpf, of the National Oceanic and Atmospheric Administration. Where the bloom will go on the lake's western end along Ohio and Michigan will vary based on wind direction, but researchers point out that most of the lake will be fine for boaters and swimmers. Other factors that will determine the size and location of this year's bloom in the coming weeks include rain amounts and the lake's water temperature. Although some areas along the Ohio shoreline already have algae starting to form and drift into the lake, researchers don't expect to see a large outbreak until the end of July.
Expect another huge blob of algae on Lake Erie this summer.

No discussion of cost. The story did an adequate job of summarizing the benefits reported in the study and putting them into context. The story stated that Folfirinox "caused more serious side effects than standard chemo" but never named them nor quantified them. The journal article reports, for example, that: 75 of those in the Folfirinox group (46%) had neutropenia compared with 35 in the Gemcitabine group (21%) 21 of those in the Folfirinox group (13%) had diarrhea compared with 3 in the Gemcitabine group (2%) 15 of those in the Folfirinox group (9%) had sensory neuropathy compared with 0 in the Gemcitabine group Adequate evaluation of the evidence, including a cautionary note from one independent expert. There was no disease-mongering of pancreatic cancer in this story. Two independent sources were quoted. Good sourcing. The focus of the story is comparing the new drug combo with the existing alternative gemcitabine. The story appropriately ended with this independent expert perspective: "doctors are testing other drug combinations to treat pancreatic cancer. She's hopeful that these combinations will work as well or better than Folfirinox, with fewer serious side effects. Folfirinox "is going to be one of a host of options" for patients, Azad says " The story never explained the availability of the drug in the US or even if it's FDA approved. The story referred to it as "newnovel combinationI see it becoming the standard of caregoing to be one of a host of options" but none of those descriptions explains whether it's approved and available now. The story refers to Folfirinox as a new drug and a novel combination, but also offers an independent expert's perspective that "doctors are testing other drug combinations to treat pancreatic cancer. She's hopeful that these combinations will work as well or better than Folfirinox, with fewer serious side effectsand that Folfirinox "is going to be one of a host of options" for patients." It's clear that the story did not rely on a news release.
New drug advances the fight against pancreatic cancer